Evidence map›Paper›PMID 33335344›Full record

ArticleNeuro-ophthalmology (Aeolus Press)2020

Visual Loss after Platelet-rich Plasma Injection into the Face.

Emely Z Karam, Alexander Gan, Rafael Muci Mendoza, Edwing Martinez, Evlyn Perez

Open access · greenAbstract readCase Reports
In one paragraph

Article in Neuro-ophthalmology (Aeolus Press), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Use of platelet rich plasma for skin rejuvenation.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Platelet-Rich Fibrin, Preparation and Use in Dermatology.Indian dermatology online journal · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Emely Z KaramNeuro-ophthalmology Department, Centro Medico Docente la Trinidad, Caracas, Venezuela.
Alexander GanNeuro-ophthalmology Department, Unidad Oftalmológica de Caracas, AVAO Universidad de Los Andes, Caracas, Venezuela.
Rafael Muci MendozaNeuro-ophthalmology Department, Hospital Vargas Caracas, Caracas, Venezuela.
Edwing MartinezNeuro-ophthalmology Department, Neurovisión Especialidades Oftalmológicas, Barquisimeto, Venezuela.
Evlyn PerezNeuro-ophthalmology Department, Centro Medico Docente la Trinidad, Caracas, Venezuela.
Centro Médico Docente La Trinidad · VEHospital Vargas · VEUniversity of the Andes · VE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Platelet-rich plasma has become one of the most widely used facial cosmetics fillers. We evaluated four patients treated by cosmetologists with platelet-rich plasma injections who developed irreversible blindness due to iatrogenic occlusion of the ophthalmic artery; immediately after the injection in the glabellar area in three cases and in the nasolabial fold in one case. Early after the injections the fundi of all patients demonstrated central retinal artery and choroidal occlusions. Later, two patients developed retinal pigment dispersion and one of them a pigmented optic disc. The scars on the skin showed similar characteristics in all patients, which could constitute an important marker in the presumptive diagnosis of platelet-rich plasma injection associated complications.

Indexed as

blindnessophthalmic artery occlusionoptic nerve pigmentationPlatelet-rich plasma

Identifiers

PMID33335344
PMCPMC7722697
OpenAlexW3013415293

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.